EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

Clinical trial NCT05261139 · RECRUITING

Trial details

NCT number

NCT05261139

Sponsor

Pfizer

Status

RECRUITING

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2022-03-07

Primary completion

2026-07-30

Enrollment

160

View on ClinicalTrials.gov